ArticleJournal of experimental & clinical cancer research : CR2022

CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1.

Xiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.